Literature DB >> 8019701

Stability characterization and formulation development of alteplase, a recombinant tissue plasminogen activator.

T H Nguyen1, C Ward.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8019701     DOI： 10.1007/978-1-4899-1236-7_3

Source DB:  PubMed          Journal:  Pharm Biotechnol        ISSN： 1078-0467


× No keyword cloud information.
  4 in total

1.  Lumenal protein within secretory granules affects fusion pore expansion.

Authors:  Annita Ngatchou Weiss; Arun Anantharam; Mary A Bittner; Daniel Axelrod; Ronald W Holz
Journal:  Biophys J       Date:  2014-07-01       Impact factor: 4.033

2.  Parathyroid hormone is a heparin/polyanion binding protein: binding energetics and structure modification.

Authors:  Tim J Kamerzell; Sangeeta B Joshi; Donald McClean; Lori Peplinskie; Karen Toney; Damon Papac; Meili Li; C Russell Middaugh
Journal:  Protein Sci       Date:  2007-06       Impact factor: 6.725

3.  Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat.

Authors:  Brad A Sutherland; Alastair M Buchan
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

4.  Slow fusion pore expansion creates a unique reaction chamber for co-packaged cargo.

Authors:  Kevin P Bohannon; Mary A Bittner; Daniel A Lawrence; Daniel Axelrod; Ronald W Holz
Journal:  J Gen Physiol       Date:  2017-09-07       Impact factor: 4.086
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.